Phase I study of ONO-7268MX2
Phase 1
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-jRCT2080222427
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
1. Patients who have the history of histologically, cytologically or clinically confirmed hepatocellular carcinoma
2. Advanced hepatocellular carcinoma patients with no standard or adequate therapeutic options
3. Life expectancy of at least 3 months
Exclusion Criteria
1. Patients with severe complication
2. Patients with multiple primary cancers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Efficacy, Pharmacological action